🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/10/2011 | 8,85 | 8,88 | 8,62 | 8,65 | -2,74% | 2,89% | 244.458 |
| 24/10/2011 | 8,71 | 8,90 | 8,57 | 8,89 | +0,92% | 3,79% | 274.113 |
| 21/10/2011 | 8,88 | 9,03 | 8,68 | 8,81 | +0,78% | 4,00% | 460.542 |
| 20/10/2011 | 8,69 | 8,85 | 8,60 | 8,74 | +1,01% | 2,87% | 347.530 |
| 19/10/2011 | 8,78 | 8,82 | 8,58 | 8,65 | -1,28% | 2,70% | 179.536 |
| 18/10/2011 | 8,55 | 8,81 | 8,52 | 8,76 | +2,78% | 3,43% | 261.610 |
| 17/10/2011 | 8,71 | 8,73 | 8,50 | 8,53 | -2,70% | 2,58% | 163.987 |
| 14/10/2011 | 8,65 | 8,83 | 8,29 | 8,76 | +2,11% | 6,28% | 166.872 |
| 13/10/2011 | 8,59 | 8,62 | 8,40 | 8,58 | -0,72% | 2,61% | 258.243 |
| 12/10/2011 | 8,49 | 8,65 | 8,30 | 8,65 | +2,74% | 4,11% | 364.202 |
| 11/10/2011 | 8,37 | 8,43 | 8,27 | 8,42 | -0,07% | 1,86% | 141.224 |
| 10/10/2011 | 8,40 | 8,44 | 8,10 | 8,42 | +2,35% | 4,09% | 492.602 |
| 07/10/2011 | 8,38 | 8,53 | 8,18 | 8,23 | -1,57% | 4,09% | 197.329 |
| 06/10/2011 | 8,46 | 8,50 | 8,18 | 8,36 | -1,11% | 3,69% | 221.855 |
| 05/10/2011 | 8,29 | 8,52 | 8,20 | 8,45 | +1,65% | 3,91% | 98.905 |
| 04/10/2011 | 7,94 | 8,33 | 7,87 | 8,32 | +3,65% | 5,89% | 386.002 |
| 03/10/2011 | 8,45 | 8,70 | 8,02 | 8,02 | -5,99% | 7,97% | 177.612 |
| 30/09/2011 | 8,40 | 8,88 | 8,27 | 8,53 | +0,29% | 7,28% | 153.407 |
| 29/09/2011 | 8,83 | 8,86 | 8,33 | 8,51 | -2,15% | 5,93% | 243.335 |
| 28/09/2011 | 9,20 | 9,26 | 8,63 | 8,70 | -5,43% | 6,85% | 169.117 |
| 27/09/2011 | 9,56 | 9,56 | 9,12 | 9,20 | +0,89% | 4,63% | 282.930 |
| 26/09/2011 | 8,89 | 9,12 | 8,74 | 9,11 | +3,18% | 4,28% | 86.883 |
| 23/09/2011 | 8,76 | 9,36 | 8,71 | 8,83 | +0,71% | 7,47% | 217.207 |
| 22/09/2011 | 8,88 | 9,11 | 8,61 | 8,77 | -4,61% | 5,62% | 323.325 |
| 21/09/2011 | 9,41 | 9,52 | 9,15 | 9,20 | -2,64% | 3,91% | 92.173 |
| 20/09/2011 | 9,38 | 9,70 | 9,38 | 9,44 | +0,87% | 3,46% | 242.694 |
| 19/09/2011 | 9,36 | 9,44 | 9,29 | 9,36 | -0,92% | 1,67% | 251.190 |
| 16/09/2011 | 9,48 | 9,60 | 9,21 | 9,45 | +0,26% | 4,14% | 592.629 |
| 15/09/2011 | 9,53 | 9,59 | 9,28 | 9,43 | -0,46% | 3,27% | 142.507 |
| 14/09/2011 | 9,59 | 9,69 | 9,41 | 9,47 | -0,59% | 2,93% | 226.023 |